Follow the people · Insider
Christopher James Stevens
Christopher James Stevens files insider transactions with the SEC as a chief operating officer of Rocket Pharmaceuticals (RCKT). We hold 1 disclosed purchase or sale filed since 6 August 2025, 1 of them in the last 90 days.
- Files forRCKT
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure13 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 4 August 2025 — 11 August 2026Chief Operating Officer · Rocket Pharmaceuticals (RCKT)9 Form 4 lines · source: SEC Form 4
Everything they disclosed
9 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 36,658 shares of Rocket PharmaceuticalsSEC Form 413 August 2026Common Stock · traded 11 August 2026 · filed 13 August 2026
- was granted 73,313 shares of Rocket PharmaceuticalsSEC Form 45 August 2026Common Stock · traded 3 August 2026 · filed 5 August 2026
- was granted 101,428 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 45 August 2026Stock Option (Right to Buy) · traded 3 August 2026 · filed 5 August 2026
- was granted 61,963 shares of Rocket PharmaceuticalsSEC Form 413 February 2026Common Stock · traded 11 February 2026 · filed 13 February 2026
- was granted 93,037 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 413 February 2026Stock Option (Right to Buy) · traded 11 February 2026 · filed 13 February 2026
- was granted 93,037 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 413 February 2026Stock Option (Right to Buy) · traded 11 February 2026 · filed 13 February 2026
- was granted 61,963 shares of Rocket PharmaceuticalsSEC Form 413 February 2026Common Stock · traded 11 February 2026 · filed 13 February 2026
- was granted 554,071 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 46 August 2025Stock Option (Right to Buy) · traded 4 August 2025 · filed 6 August 2025
- was granted 407,166 shares of Rocket PharmaceuticalsSEC Form 46 August 2025Common Stock · traded 4 August 2025 · filed 6 August 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.